Celldex Therapeutics
CLDX
#4346
Rank
A$3.94 B
Marketcap
A$50.23
Share price
-0.59%
Change (1 day)
48.64%
Change (1 year)

Market capitalization of Celldex Therapeutics (CLDX)

Market cap: A$3.94 Billion

As of July 2026 Celldex Therapeutics has a market cap of A$3.94 Billion. This makes Celldex Therapeutics the world's 4346th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celldex Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.94 B50.54%
2025A$2.61 B-3.29%
2024A$2.70 B-14.93%
2023A$3.18 B3.2%
2022A$3.08 B23.86%
2021A$2.49 B176.01%
2020A$0.90 B1569.28%
2019A$54.05 M7.29%
2018A$50.38 M-89.81%
2017A$0.49 B-0.51%
2016A$0.49 B-76.59%
2015A$2.12 B6.32%
2014A$1.99 B-17.52%
2013A$2.42 B482.9%
2012A$0.41 B271.22%
2011A$0.11 B-13.9%
2010A$0.13 B-21.07%
2009A$0.16 B-7.07%
2008A$0.17 B317.77%
2007A$42.42 M-66.6%
2006A$0.12 B-33.33%
2005A$0.19 B-1.03%
2004A$0.19 B-19.28%
2003A$0.23 B96.25%
2002A$0.12 B-74.41%
2001A$0.47 B-32.4%
2000A$0.70 B288.58%
1999A$0.18 B48.84%
1998A$0.12 B22.62%
1997A$99.08 M143.35%
1996A$40.71 M

End of Day market cap according to different sources

On Jul 20th, 2026 the market cap of Celldex Therapeutics was reported to be:

A$3.96 Billion
by Nasdaq info icon info icon
A$3.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$201.72 B 5,016.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$280.43 B 7,012.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$144.61 B 3,567.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
A$8.74 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A$61.56 B 1,461.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.32 B-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.56 B-85.76%๐Ÿ‡บ๐Ÿ‡ธ USA